The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

July 2009

Volume 49, Issue 7

Pages 758–874

  1. Review

    1. Top of page
    2. Review
    3. Special Populations
    4. Pharmacokinetics
    5. Drug Interactions
    6. Pharmacodynamics
    7. Clinical Impact
    1. Effect of Glucose—Insulin—Potassium Infusion on Mortality in Critical Care Settings: A Systematic Review and Meta-Analysis (pages 758–767)

      Dr Michael A. Puskarich, Dr Michael S. Runyon, Dr Stephen Trzeciak, Dr Jeffrey A. Kline and Dr Alan E. Jones

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009334375

  2. Special Populations

    1. Top of page
    2. Review
    3. Special Populations
    4. Pharmacokinetics
    5. Drug Interactions
    6. Pharmacodynamics
    7. Clinical Impact
    1. Propofol Clearance and Volume of Distribution Are Increased in Patients With Major Burns (pages 768–772)

      Dr Tae-Hyung Han, Dr David J. Greenblatt and Dr J. A. Jeevendra Martyn

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009335767

    2. Limited Sampling Strategies for the Estimation of Sirolimus Daily Exposure in Kidney Transplant Recipients on a Calcineurin Inhibitor—Free Regimen (pages 773–781)

      Dr Dario Cattaneo, Dr Monica Cortinovis, Dr Sara Baldelli, Dr Eliana Gotti, Dr Giuseppe Remuzzi and Dr Norberto Perico

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009332811

    3. Prospective Evaluation of the Bayesian Method for Individualizing Tacrolimus Dose Early After Living-Donor Liver Transplantation (pages 789–797)

      Dr Masahide Fukudo, Dr Ikuko Yano, Ms Keiko Shinsako, Dr Toshiya Katsura, Dr Yasutsugu Takada, Dr Shinji Uemoto and Dr Ken-ichi Inui

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009333853

  3. Pharmacokinetics

    1. Top of page
    2. Review
    3. Special Populations
    4. Pharmacokinetics
    5. Drug Interactions
    6. Pharmacodynamics
    7. Clinical Impact
    1. Pharmacokinetics, Safety, and Tolerability of Doripenem After 0.5-, 1-, and 4-Hour Infusions in Healthy Volunteers (pages 798–806)

      Iolanda Cirillo, Nicole Vaccaro, Kenneth Turner, Bhavna Solanki, Jaya Natarajan and Rebecca Redman

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009337012

  4. Drug Interactions

    1. Top of page
    2. Review
    3. Special Populations
    4. Pharmacokinetics
    5. Drug Interactions
    6. Pharmacodynamics
    7. Clinical Impact
    1. The Effect of Etoricoxib on the Pharmacokinetics of Oral Contraceptives in Healthy Participants (pages 807–815)

      Dr Jules Schwartz, Dr Thomas Hunt, Dr William B. Smith, Dr Peggy Wong, Mr Patrick Larson, Ms Tami Crumley, Mr Anish Mehta, Dr Keith Gottesdiener and Dr Nancy Agrawal

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009337131

    2. Lack of Pharmacokinetic Drug Interactions Following Concomitant Administration of Telavancin with Aztreonam or Piperacillin/Tazobactam in Healthy Participants (pages 816–823)

      Dr Shekman L. Wong, Dr Fritz Sörgel, Dr Martina Kinzig, Dr Michael R. Goldberg, Dr Michael M. Kitt and Dr Steven L. Barriere

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009337133

    3. The Absence of an Interaction Between Warfarin and Cranberry Juice: A Randomized, Double-Blind Trial (pages 824–830)

      Dr Jack Ansell, Ms Maryellen McDonough, Ms Yanli Zhao, Mr Jerold S. Harmatz and Dr David J. Greenblatt

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009337510

  5. Pharmacodynamics

    1. Top of page
    2. Review
    3. Special Populations
    4. Pharmacokinetics
    5. Drug Interactions
    6. Pharmacodynamics
    7. Clinical Impact
    1. Statin Effects on LDL and HDL Cholesterol in South Asian and White Populations (pages 831–837)

      Dr Milan Gupta, Dr Manoela F. B. Braga, Dr Hwee Teoh, Ms Michelle Tsigoulis and Dr Subodh Verma

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009334376

    2. The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study (pages 838–847)

      Dr Alejandra Meaney, Dr Guillermo Ceballos, Dr Juan Asbun, Dr Gustavo Solache, Ms Emma Mendoza, Dr Agustín Vela and Dr Eduardo Meaney

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009337011

    3. Methylphenidate Has Positive Hypocholesterolemic and Hypotriglyceridemic Effects: New Data (pages 848–851)

      Gideon Charach, Nehemia Kaysar, Itamar Grosskopf, Alexander Rabinovich and Moshe Weintraub

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009336736

    4. Response of Vitiligo to Narrowband Ultraviolet B and Oral Antioxidants (pages 852–855)

      Maha Elgoweini and Nagwa Nour El Din

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009335769

    5. Single-Dose Administration of MK-0657, an NR2B-Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease (pages 856–864)

      Dr Carol Addy, Dr Chris Assaid, Mr David Hreniuk, Dr Mark Stroh, Dr Yang Xu, Dr W. Joseph Herring, Dr Aaron Ellenbogen, Dr H. A. Jinnah, Dr Louis Kirby, Dr Mark T. Leibowitz, Dr R. Malcolm Stewart, Dr Daniel Tarsy, Dr James Tetrud, Dr S. Aubrey Stoch, Dr Keith Gottesdiener and Dr John Wagner

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009336735

  6. Clinical Impact

    1. Top of page
    2. Review
    3. Special Populations
    4. Pharmacokinetics
    5. Drug Interactions
    6. Pharmacodynamics
    7. Clinical Impact
    1. Iatrogenic Severe Depression of High-Density Lipoprotein Cholesterol (pages 865–871)

      Dr D. Mymin, Dr T. Dembinski and Dr M. H. Friesen

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009335766

SEARCH

SEARCH BY CITATION